• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Light Sciences Oncology

edit

Light Sciences Oncology, Inc. develops of cancer and tumor treatment drugs. Additionally, it offers oncology drugs research and development services to treat hepatocellular carcinoma, metastatic colorectal cancer, and glioma. Light Sciences Oncology was founded in 1994 and is headquartered in Bellevue, Washington.

Milestones

edit

• 
  Light Sciences Oncology added Robert M. Littauer as CFO.
  Posted 11/6/09 at 6:11pm
• 
  Light Sciences Oncology added Llew Keltner as CEO.
  Posted 11/6/09 at 6:11pm
• 
  Light Sciences Oncology received $67M in Series A funding. (12/14/05)
  Posted 7/1/10 at 3:25am via lsoncology.com
• 
  Light Sciences Oncology received $30M in Series B funding. (7/11/07)
  Posted 3/11/10 at 8:34pm via venturebeat.com
• 
  Light Sciences Oncology received $35M in Unattributed funding. (11/1/09)
  Posted 11/6/09 at 6:11pm via fiercebiotech.com

Videos

Screenshots

edit

Above: Light Sciences Oncology
Uploaded: 3/12/10

Sources

1. LIGHT SCIENCES ONCOLOGY COMPLETES SECOND CLOSING IN $67 MILLION FINANCING FOR LATE STAGE DEVELOPMENT OF LITXâ„¢ AND ANNOUNCES ADDITIONAL DIRECTORS (lsoncology.com) [edit]
2. Light Sciences beams up $30M (venturebeat.com) [edit]
3. Light Sciences lines up $35M in credit, financing (fiercebiotech.com) [edit]